GS-9911
/ Gilead, Carna Biosci
- LARVOL DELTA
Home
Next
Prev
1 to 3
Of
3
Go to page
1
December 07, 2023
Study of GS-9911 With or Without Antibody Treatment for Adults With Solid Tumors
(clinicaltrials.gov)
- P1 | N=120 | Recruiting | Sponsor: Gilead Sciences
Combination therapy • Metastases • Monotherapy • Trial completion date • Trial primary completion date • Oncology • Solid Tumor
November 15, 2023
Study of GS-9911 With or Without Antibody Treatment for Adults With Solid Tumors
(clinicaltrials.gov)
- P1 | N=120 | Recruiting | Sponsor: Gilead Sciences | Not yet recruiting ➔ Recruiting
Combination therapy • Enrollment open • Metastases • Monotherapy • Oncology • Solid Tumor
October 13, 2023
Study of GS-9911 With or Without Antibody Treatment for Adults With Solid Tumors
(clinicaltrials.gov)
- P1 | N=120 | Not yet recruiting | Sponsor: Gilead Sciences
Combination therapy • Metastases • Monotherapy • New P1 trial • Oncology • Solid Tumor
1 to 3
Of
3
Go to page
1